Conferences and symposiums NextGenNK and CCRM Nordic mini-symposium
Advanced Medicinal Therapy Products, ATMP, span broadly over medical fields and the aim of this symposium is to enhance networking within ATMP and to get a flavor of academic and commercial development of ATMPs in Stockholm and Sweden. NextGenNK and CCRM Nordic are inviting you to a mini-symposium with the focus on ATMP on January 22, 2025. Last day to register is January 17, 2025.
Organizers
Photo: N/ANextGenNK
Photo: N/ACCRM Nordic
Agenda
12:30 Mingle Lunch
13:00 Welcome Remarks: Hans-Gustaf Ljunggren, NextGenNK
13:05 Opening Talk: Johan Ericson, Karolinska Institutet - “Development of a therapeutically high-effective cell product for Parkinson´s disease”
13:20 Cristiana Pires, Asgard Therapeutics - "In vivo reprogramming for cancer immunotherapy"
13:35 Johan Flygare, Lund University - "Towards clinical gene therapy for Diamond-Blackfan Anemia"
13:50 Cecilia Götherström, Karolinska Institutet - “Revolutionizing Treatment: Stem Cell Therapy for Brittle Bone Disease”
14:05 Angelica Loskog, Lokon Pharma, Uppsala University - ”TME Gene Engineering of Checkpoint Refractory Malignant Melanoma”
14:20 Pontus Blomberg, Vecura - TBA
14:35 Fredrik Wessberg, CCRM Nordic - TBA
14:45 Coffee Break
15:15 Keynote Presentation: Peter Zandstra, CCRM, University of British Columbia - “Production of allogeneic CAR-T cells and CD4+ T cells from iPSCS to advance immunotherapies”
15:40 Ted Smith / Rula Zain, Karolinska Institutet - TBA
15:55 Ebba Sohlberg, Karolinska Institutet - “ADAPT-NK - an off-the-shelf cell therapy to unleash NK cell potential”
16:10 Sarah Saietz, Karolinska Institutet - "Embryonic stem cell-based treatment of retinal degenerative diseases"
16:25 Stephan Mielke, CAST - “Overcoming fragmentation in translation of innovation in advanced cell- and gene therapy”
16:40 Antje Zickler, Karolinska Institutet - “Engineered exosomes for the delivery of genetic medicines”
16:55 Matti Sällberg, Karolinska Institutet - “Getting into clinical trials with genetic vaccines”